¡Atención! Este sitio usa cookies y tecnologías similares.

Si no cambia la configuración de su navegador, usted acepta su uso. Saber más

Acepto

Bibliografía

Bibliografía coenzima Q10

 

  • Bhagavan HN, Chopra RK. Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006;40(5):445-453
  • Beal MF. Coenzyme Q10 as Possible Treatment for Neurodegenerative Diseases. Free Radic Res 2002;36(4):455-460
  • Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Principi F, Tiano L, Littarru GP. Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure. Biofactors 2005;25:137-145
  • Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GP. Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J 2006;27:2675-2681
  • Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007;S7:s41-s50
  • Block G, Jensen CD, Norkus EP, Dalvi TB, Wong LG, McManus JF, Hudes ML. Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study. Nutrition J 2007;6:30.
  • Bonakdar RA, Guarneri E. Coenzyme Q10. Am Fam Physician 2005;72:1065-1070
  • Buettner C, Phillips RS, Davis RB, Gardiner P, Mittleman MA. Use of Dietary Supplements Among United States Adults With Coronary Artery Disease and Atherosclerotic Risks. Am J Cardiol 2007;99:661-666
  • Cleren C, Yang L, Lorenzo B, Calingasan NY, Schomer A, Sireci A, Wille EJ, Beal MF. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J neurochem 2008;104:1613-1621
  • Fabian E, Pölöskey P, Kósa L, Elmadfa I, Réthy LA (2013). " Nutritional supplements and plasma antioxidants in chilhood asthma" Wien Klin Wochenschr. May 1
  • Fotino AD, Thompson-Paul AM. Effect of coenzyme Q10 supplementation on  heart failure: a meta-analysis. Am J Clin Nutr. 2013 Feb;97(2):268-75 
  • Gazdik, F., A. Gvozdjakova, et al. (2002). "Levels of coenzyme Q10 in asthmatics." Bratisl Lek Listy 103(10): 353-356.
  • Gazdik, F., A. Gvozdjakova, et al. (2002). "Decreased levels of coenzyme Q(10) in patients with bronchial asthma." Allergy 57(9): 811-814.
  • Gvozdjáková A, Kucharská J, Bartkovjaková M, Gazdíková K, Gazdík F. Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma. Biofactors 2005;25:235-240
  • Hathcock J, Shao A. Risk assessment for coenzyme Q10 (Ubiquinone). Regul Toxic Pharmacol 2006;45:282-288.
  • Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutrition 2002;56:1137-1142
  • Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M. Study on safety and bioavailability of ubiquinol (Kaneka QHTM) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxic Pharmacol 2007;47:19-28.
  • Kaikkonen J, Tuomainene TP, Nyyssönen K, Salonen KT. Coenzyme Q10: Absorption, Antioxidative Properties, Determinants, and Plasma Levels. Free Radic Res 2002;36(4):389-397
  • Kendler BS.  Supplemental conditionally essential nutrients in cardiovascular disease therapy. J. Cardiovasc Nurs. 2006 Jan-Feb;21(1):9-16.
  • Lenaz, G., R. Fato, et al. (1994). "An updating of the biochemical function of coenzyme Q in mitochondria." Mol Aspects Med 15 Suppl: s29-36.
  • Littarru GP, Langsjoen P. Coenzyme Q10 and statins: Biochemical and clinical implications. Mitochondrion 2007;S7:s168-s174
  • Mabuchi H, Higashikata T, Kawashiri M, Katsuda S, Mizuno M, Nohara A, Inazu A, Koizumi J, Kobayashi J. Reduction of Serum Ubiquinol-10 and Ubiquinone-10 Levels by Atorvastatin in Hypercholesterolemic Patients. J Athorescl Thromb 2005;12(2):111-119.
  • Mancini A, Corbo GM, Gaballo A, Valente S, Gigliotti P, Cimino V, De Marinis L, Principi F, Littarru GP. Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. Biofactors 2005;25:201-204
  • Miles MV. The uptake and distribution of coenzyme Q(10). Mitochondrion 2007;S7:s72-s77
  • Mitsui, T., Y. Umaki, et al. (2003). "Motor neuron involvement in a patient with long-term corticosteroid administration." Intern Med 42(9): 862-866.
  • Molyneux SL, Young JM, Florkowski CM, Lever M, George PM. Coenzyme Q10: Is There a Clinical Role and a Case of Measurement? Clin Biochem Rev 2008;29:71-82
  • Mortensen SA. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio" - A multinational trial. Biofactors 2003;18:79-89
  • Niklowitz P, Sonnenschein A, Janetzky B, Andler W, Menke T. Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage. Int J Biol Sci 2007;3:257-262
  • Nukui K, Matsuoka Y, Yamagishi T, Miyawaki H, Sato K. Safety Assessment Of PureSorb-QTM 40 in Healthy Subjects and Serum Coenzyme Q10 Level in Excessive Dosing. J Nutr Sci Vitaminol 2007;53:198-206.Pepe S, Marasco SF, Haas SJ, Sheeran FL, Krum H, Rosenfeldt FL. Coenzyme Q10 in cardiovascular disease. Mitochondrion 2007;S7:s154-s167
  • Pepe S, Marasco SF, Haas SJ, Sheeran FL, Krum H, Rosenfeldt FL. Coenzyme Q10 in cardiovascular disease. Mitochondrion 2007;S7:s154-s167
  • Quinzii CM, DiMauro S, Hirano M. Human Coenzyme Q10 Deficiency. Neurochem Res 2007;32:723-727
  • Quinzii CM, Hirano M, DiMauro S. CoQ10 deficiency diseases in adults. Mitochondrion 2007;7:s122-s126
  • Sander S, Coleman CI, Patel AA, Kluger J, White M. The Impact of Coenzyme Q10 on Systolic Function in Patients With Chronic Heart Failure. J Cardiac Failure 2006;12(6):464-472
  • Sena et al....Arch Med Sci 2008
  • Shalansky, S., L. Lynd, et al. (2007). "Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis." Pharmacotherapy 27(9): 1237-1247.
  • Shargorodsky M, Debby O,  Matas Z, Zimlichman R. (2010). Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutrition & Metabolism 2010, 7:55.
  • Suzuki T, Nozawa T, Sobajima M, Igarashi N, Matsuki A, Fujii N, Inoue H. Atorvastatin-Induced changes in Plasma Coenzyme Q10 and Brain Natriuretic Peptide in Patients With Coronary Artery Disease. Int Heart J 2008;49:423-433.
  • Tsujita Y, Kunitomo T, Fujii M, Furukawa S, Otsuki H, Fujino K, Hamamoto T, Tabata T, Matsumura K, Sasaki T, Saotome T, Kawai H, Matsumoto T, Maeda K, Horie M, Eguchi Y. A surviving case of mitochondrial cardiomyopathy diagnosed from the symptoms of multiple organ dysfunction syndrome. Int J Cardiol 2008;128:e43-e45.
  • Weber C, Bysted A, Hølmer G. Coenzyme Q10 in the Diet-Daily Intake and Relative Bioavailability. Molec Aspects Med 1997;18:s251-s254
  • Witte KKA, Nikitin NP, Parker AC, von Haehling S, Volk HD, Anker SD, Clark AL, Cleland JGF. The effect of micronutrient supplementation on quiality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005;25:2238-2244
  • Zita C, Overvad K, Mortensen SA, Sindberg CD, Moesgaard S, Hunter DA. Serum coenzyme Q10 concentrations in healthy men supplemented with 30 mg or 100 mg coenzyme Q10 for two months in a randomised controlled study. Biofactors 2003;18:185-193
  • Zhou, Q., S. Zhou, et al. (2005). "Effect of coenzyme Q10 on warfarin hydroxylation in rat and human liver microsomes." Curr Drug Metab 6(2): 67-81.
  • Cordero MD, Alcocer-Gómez E, de Miguel M, Cano-García FJ, Luque CM, Fernández-Riejo P, Fernández AM, Sánchez-Alcazar JA. Coenzyme Q(10): a novel therapeutic approach for  fibromyalgia? Case series with 5 patients. Mitochondrion. 2011 Jul;11(4):623-5.
  • Cordero MD, de Miguel M, Carmona López, P Bonal, Campa F, Moreno-Fernández I. Estrés oxidativo y la disfunción mitocondrial en la fibromialgia. Neuro Endocrinol Lett. 2010; 31 (2): 169-73.
  • Cordero MD, et. al. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the diseaseLa disfunción mitocondrial y la activación mitophagy en las células mononucleares de la sangre de los pacientes con fibromialgia: implicaciones en la patogénesis de la enfermedad. 1, 2BioMed Central, Ltd. 2010).  Copyright ©2010 Sánchez Alcázar et al.; licensee BioMed Central, Ltd.
  • Cordero MD, Moreno-Fernández AM, deMiguel M, Bonal P, Campa F, Jiménez-Jiménez LM, Ruiz-Losada A, Sánchez-Domínguez B, Sánchez Alcázar JA, Salviati L, Navas P. Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. Clin Biochem. 2009 May;42(7-8):732-5.
  • Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol Lett. 2009;30(4):470-6.
  • Maes M , Mihaylova I , Kubera M , Uytterhoeven M , Vrydags N , Bosmans E .
  • Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett. 2009;30 (4):462-9.
  • Maes M, Twisk FN. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS. Neuro Endocrinol Lett. 2009;30 (6):677-93)
  • Neustadt J, Pieczenik SR. Medication-induced mitochondrial damage and disease. Mol Nutr Food Res. 2008 Jul;52(7):780-8. 
  • Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev. 2000 Apr;5(2):93-108.